Abstract
The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the artificial intelligence in diabetes management market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the artificial intelligence in diabetes management market on a global level.
In order to give the users of this report a comprehensive view of the artificial intelligence in diabetes management market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a customer and region segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.
The study provides a decisive view of the artificial intelligence in diabetes management market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.
Based on devices, the global artificial intelligence in diabetes management market is segmented into four types: glucose monitoring devices, diagnostic devices, insulin delivery devices, and other devices. Based on techniques, the market is segmented into two types case-based reasoning and intelligent data analysis.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries including the U.S. Germany, France, the UK, China, Japan, India, and Brazil. This segmentation includes demand for artificial intelligence in diabetes management based on individual segment and applications in all the regions and countries.
The report covers detailed competitive outlook including the market share, reimbursement policy, and company profiles of the key participants operating in the global artificial intelligence in diabetes management market include Apple Inc., Diabnext, Glooko Inc., Google Inc., IBM Corporation, Tidepool, and Vodafone Group Plc.
This report segments the global artificial intelligence in diabetes management market as follows:
Global Artificial Intelligence in Diabetes Management Market: Device Type Analysis
Glucose Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Global Artificial Intelligence in Diabetes Management Market: TechniqueType Analysis
Case-based Reasoning
Intelligent Data Analysis
Global Artificial Intelligence in Diabetes Management Market: Regional Segment Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa